Today at its annual conference in Sydney the Australian Self Medication Industry shared a ‘sample mock ad’, which demonstrated the proposed consumer communication model it has been advocating for Schedule 3 products. A fictitious brand was created in an existing S3 category that cannot be advertised – “Brand FAM” (Famciclovir) for cold sore treatment. Current
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.